You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 301 No. 1, January 7, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Crossroads: Conferences With Patients and Doctors
 This Article
 •Full text
 •PDF
 •Interactive eFigure
 •CME Course for This Article
 • Submit Response to Patient's Crossroads
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 • Readers Responses
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Surgery
 •Surgical Interventions
 •Urology
 •Women's Health
 •Gynecology
 •Hematology/ Hematologic Malignancies
 •Anemias
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

CLINICIAN'S CORNER
A 41-Year-Old Woman With Menorrhagia, Anemia, and Fibroids

Review of Treatment of Uterine Fibroids

Bradley Van Voorhis, MD, Discussant

JAMA. 2009;301(1):82-93.

Uterine fibroids are common tumors that can cause heavy menstrual bleeding, pelvic pressure symptoms, and reproductive disorders. The incidence of fibroids peaks in the fifth decade of age and they are more common in African American women. Often, fibroids are asymptomatic and require no treatment. However, the case of Ms P, a 41-year-old woman with recurrent uterine fibroids, menorrhagia, anemia, and fatigue who wishes to retain fertility, illustrates the symptoms that require treatment. Evaluation usually begins with a pelvic examination and an ultrasound to determine both the size and location of the fibroids within the uterus. Standard treatment of symptomatic fibroids is surgical removal by myomectomy or hysterectomy, depending in part on the desire for future fertility; new treatment options include uterine artery embolization via interventional radiologic techniques as well as various medical interventions. Several new therapies show promise but are still experimental at this time. The evidence for treatment options for Ms P and symptomatic patients with fibroids in general is discussed.


Author Affiliation: Dr Van Voorhis is F. K. "Ted" Chapler Professor of Obstetrics and Gynecology and Director of the Reproductive Endocrinology Division at University of Iowa Carver College of Medicine, Iowa City.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

RELATED ARTICLE

Uterine Fibroids
Carolyn J. Hildreth, Cassio Lynm, and Richard M. Glass
JAMA. 2009;301(1):122.
EXTRACT | FULL TEXT  




RAPID RESPONSES TO THIS ARTICLE

A 41-Year-Old Woman Suffering with Fibroids
John C Lipman
JAMA Online, 2 Jan 2009.
TEXT 

Uterine fibroids: The disconnect between treatment options and patient expectations
Kristen A. Matteson
JAMA Online, 2 Jan 2009.
TEXT 



HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.